Pharma BD Deal Intelligence
Johnson & Johnson / Synthes Inc.
2011 · Acquisition/Merger · $19.7B · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
77
Worked — the deal delivered on its rationale.
J&J acquired Synthes for $19.7B for orthopedic implants and trauma devices.
Did it work? Outcome assessment
J&J / Synthes: Partially Achieved (Score: 47/100)
Strategic verdict
Partially Achieved
Assessment window: 5yr post-close.
Key facts
- Announced Apr 27, 2011
- Closed Jun 14, 2012
- Deal value $19.7B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals